Inhibition of epidermal growth factor receptor tyrosine kinase ameliorates collagen-induced arthritis.
Inhibition of epidermal growth factor receptor tyrosine kinase ameliorates collagen-induced arthritis.
复制标题
DOI:
10.4049/jimmunol.1102693
复制
发表时间:
2012-04-01
期刊:
影响因子:
--
通讯作者:
Robinson WH
中科院分区:
文献类型:
--
作者:
Swanson CD;Akama-Garren EH;Stein EA;Petralia JD;Ruiz PJ;Edalati A;Lindstrom TM;Robinson WH
Rheumatoid arthritis (RA) is an autoimmune synovitis characterized by the formation of pannus and the destruction of cartilage and bone in the synovial joints. Although immune cells, which infiltrate the pannus and promote inflammation, play a prominent role in the pathogenesis of RA, other cell types also contribute. Proliferation of synovial fibroblasts, for example, underlies the formation of the pannus, while proliferation of endothelial cells results in neovascularization, which supports the growth of the pannus by supplying it with nutrients and oxygen. The synovial fibroblasts also promote inflammation in the synovium by producing cytokines and chemokines. Finally, osteoclasts cause the destruction of bone. Here we show that erlotinib, an inhibitor of the tyrosine kinase EGFR, reduces the severity of established collagen-induced arthritis (CIA), a mouse model of RA—and that it does so by targeting synovial fibroblasts, endothelial cells, and osteoclasts. Erlotinib-induced attenuation of autoimmune arthritis was associated with a reduction in number of osteoclasts and blood vessels, and erlotinib inhibited the formation of murine osteoclasts and the proliferation of human endothelial cells in vitro. Erlotinib also inhibited the proliferation and cytokine production of human synovial fibroblasts in vitro. Moreover, EGFR was highly expressed and activated in the synovium of mice with CIA and patients with RA. Together, these findings suggest that EGFR plays a central role in the pathogenesis of RA and that EGFR inhibition may provide benefit in the treatment of RA.
登录
查看更多内容
影响因子:
6.7
作者:
Lu, Jian-Feng;Eppler, Steve M.;Lum, Bert L.
通讯作者:
Lum, Bert L.
影响因子:
2.1
作者:
Hallbeck, AL;Walz, TM;Wasteson, Å
通讯作者:
Wasteson, Å
影响因子:
27.4
作者:
FITZGERALD, O;SODEN, M;BRESNIHAN, B
通讯作者:
BRESNIHAN, B
影响因子:
3.8
作者:
GODDARD D H;GROSSMAN S L;MOORE M E
通讯作者:
MOORE M E
影响因子:
1.8
作者:
Mehta, Veela B.;Zhou, Yu;Besner, Gail E.
通讯作者:
Besner, Gail E.